Omada Health Announces Launch of Initial Public Offering

May 29, 2025 at 06:14 AM EDT

Omada Health, the virtual between-visit healthcare provider, announced today that it has launched the roadshow for its proposed initial public offering of its common stock. Omada Health has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) to offer an aggregate of 7,900,000 shares of its common stock. In addition, Omada Health intends to grant the underwriters a 30-day option to purchase up to an additional 1,185,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $18.00 and $20.00 per share. Omada Health has applied to list its common stock on the Nasdaq Global Market under the ticker symbol “OMDA.”

Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan are acting as lead book-running managers for the proposed offering. Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering. Canaccord Genuity and Needham & Company are acting as co-managers for the proposed offering.

The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, or by email at prospectus@morganstanley.com; Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316, or by email at prospectus-ny@ny.email.gs.com; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at prospectus-eq_fi@jpmorgan.com and postsalemanualrequests@broadridge.com.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Omada Health

Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.